HIKAL

Business Performance – Broad Trends

🏢 1. Company Overview Hikal is a long-established company operating in: Pharmaceutical APIs Pharma intermediates Crop protection chemicals They operate as a contract manufacturer for global pharma and agrochemical companies, offering long-term supply partnerships and custom synthesis. 📊 2. Business Performance – Broad Trends (General long-term patterns, not real-time news) Pharma segment contributes a major share of revenue; growth is driven by regulated markets and multi-year contracts. Crop protection segment is more cyclical and depends heavily on global demand from agrochemical giants. Margins tend to fluctuate depending on raw material prices (many inputs come from China). Capacity expansions over the past few years position the company for scale-based growth. 🚀 3. Growth Drivers (6–24 Month Outlook) 1. Recovery in Agrochem Demand The agrochemical industry went through inventory correction globally. A demand recovery can directly boost Hikal’s volumes. 2. Pharma API Diversification Hikal has been adding molecules in chronic therapy areas (CNS, anti-diabetic, cardiovascular), which can support long-term revenue stability. 3. Contract Manufacturing Deals More global pharma companies are outsourcing manufacturing to India. Hikal can benefit due to: Compliance track record Long-term relationships Integrated facilities